Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Type 1 Human Immunodeficiency Virus (HIV-1) Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-exposure Prophylaxis: Pooled Analysis From 72 Global Studies

Clinical Infectious Diseases(2024)10.1093/cid/ciae143Source: DataRank Database

Type 1 Human Immunodeficiency Virus (HIV-1) Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-exposure Prophylaxis: Pooled Analysis From 72 Global Studies is a research paper published in Clinical Infectious Diseases (2024). On theSindex it has a DataRank of 0. It has been cited 19 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access19 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (16 grants)OA: hybridTopics (95)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (63)

Tao Li ORCID,Juan Yang ORCID,Melanie de Boer ORCID,Christoph C Carter ORCID,Moupali Das ORCID

Live enrichment

PubMed:38484128 PMC:PMC7616831

California HIV-1 Research Program

Grant: EI11-LA-002

California HIV-1 Research Program

Grant: R01AA022067

National Institutes of Mental Health

Grant: R01MH108412

National Institutes of Mental Health

Grant: R01MH106369

Medical Research Council

Grant: MC_UU_00004/03

Blood borne viruses

European & Developing Countries Clinical Trials Partnership (EDCTP)

Grant: RIA2016V-1644

NIMH NIH HHS

Grant: P30 MH058107

National Institute for Health Research (NIHR)

Grant: RP-PG-1212-20006

Wellcome Trust

Grant: unidentified

unidentified

National Institutes of Health

Grant: 7R01MH108412-04

PrEP uptake/adherence to reduce periconception HIV risk for South African women

National Institutes of Health

Grant: 3R01AA022067-04S1

Intervention to Enhance PrEP Uptake and Adherence in a Community-Based Setting

National Institutes of Health

Grant: 5R01MH106369-03

Dyadic-Based Diagnosis, Care, & Prevention for HIV Discordant Couples in Tanzania

Doris Duke Foundation

Gilead Sciences, Inc.

NIH HHS

National Institutes of Health

hybridLicense: CC BY

publisherhttps://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciae143/57271329/ciae143.pdf

publisherhttps://academic.oup.com/cid/article-pdf/79/5/1197/60779440/ciae143.pdf

Europe_PMChttps://europepmc.org/articles/PMC7616831

Europe_PMChttps://europepmc.org/articles/PMC7616831?pdf=render

https://doi.org/10.1093/cid/ciae143

Fields of Study

0301 basic medicine0302 clinical medicine03 medical and health sciences

MeSH Terms

HumansHIV-1HIV InfectionsAnti-HIV AgentsDrug MonitoringIncidenceProspective StudiesDrug Resistance, ViralAdultMiddle AgedFemaleMaleYoung AdultPre-Exposure ProphylaxisTenofovirEmtricitabineEmtricitabine, Tenofovir Disoproxil Fumarate Drug Combination

Keywords

HIV-1Tenofovir Disoproxil FumarateemtricitabinePre-exposure ProphylaxisPrevention (rcdc)MaleWomen's Health (rcdc)Assessment of Medication Adherence (mesh)Tenofovir Disoproxil Fumarate Drug Combination (mesh)Drug ResistanceHealth Disparities (rcdc)HIV Infections11 Medical and Health Sciences (for)Medical and Health SciencesClinical Research (rcdc)Emtricitabine (mesh)ViralProspective Studies32 Biomedical and Clinical Sciences (for-2020)Male (mesh)Humans (mesh)Young Adult (mesh)3 Good Health and Well Being (sdg)IncidenceEmtricitabine, Tenofovir Disoproxil Fumarate Drug CombinationBiological SciencesMiddle Aged06 Biological Sciences (for)Health DisparitiesInfection (hrcs-hc)Infectious DiseasesMedical MicrobiologyHIV/AIDSFemaleDrug MonitoringInfectionAdultAnti-HIV AgentsTenofovir (mesh)Clinical SciencesClinical Trials and Supportive ActivitiesClinical Trials and Supportive Activities (rcdc)610HIV Infections (mesh)MicrobiologyMedication AdherenceYoung AdultClinical ResearchIncidence (mesh)Viral (mesh)616Middle Aged (mesh)Drug Resistance, ViralMajor ArticleHumans3207 Medical Microbiology (for-2020)Tenofovir Disoproxil Fumarate Drug CombinationProspective Studies (mesh)TenofovirGlobal F/TDF PrEP Study Team3202 Clinical Sciences (for-2020)Pre-Exposure Prophylaxis (mesh)HIV/AIDS (rcdc)HIV-1 (mesh)Biomedical and Clinical SciencesPreventionAnti-HIV Agents (mesh)Good Health and Well BeingInfectious Diseases (rcdc)Female (mesh)Microbiology (science-metrix)Adult (mesh)Sexually Transmitted InfectionsWomen's HealthSexually Transmitted Infections (rcdc)